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Hypoxia endangers the survival of cells and organisms. Mutations in an enzyme that attaches amino acids to
tRNAs to supply protein synthesis confer resistance to hypoxia in C. elegans. By slowing down protein
synthesis (a major consumer of energy), such mutations may save valuable energy and/or prevent accumu-
lation of malfolded proteins.
DOI 10.1016/j.cmet.2009.03.007Protein synthesis is a fundamentally impor-
tant cellular process, being both a key
stage ingeneexpressionandarequirement
for cell growth and proliferation. Protein
synthesis also places heavy demands
upon the cell: it consumes a high propor-
tion of cellular energy and also requires
machinery to ensure proteins are correctly
folded into their functional 3D structures.
Oxidative metabolism is the most effective
way to provide cells with these resources.
Thereare several situationsof major clinical
importance where restricted oxygen
supply (hypoxia) leads to serious adverse
consequences—examples include stroke
and heart attacks (myocardial infarction).
The interior of solid tumors may also be
hypoxic. In their recent study, Anderson
et al. (2009) conducted a screen for muta-
tions that would confer resistance to
hypoxia using the genetically tractable
nematode worm, C. elegans. They discov-
ered that a mutation in the gene rrt-1, which
encodes an arginyl-tRNA synthetase,
allows worms to resist hypoxia-induced
death.
Prior to incorporation into the new poly-
peptide chain, amino acids are attached
to transfer RNAs (tRNAs) by enzymes
termed aminoacyl-tRNA synthetases
(AARSs). The resulting charged tRNAs
are used by the ribosomal protein
synthesis machinery to add the correct
amino acid corresponding to each codon
in the mRNA. In most organisms there is a
different AARS for each of the 20 normally
occurring amino acids, each of which will
‘‘charge’’ all the tRNAs within a given
isoacceptor family. In addition to this
cytoplasmic tRNA charging machinery,
mitochondria also need a complete com-
plement of AARSs (mAARS), usually en-
coded by nuclear genes.This effect is by no means specific for
the arginyl-tRNA synthetase; Anderson
et al. show that ‘‘knocking down’’ expres-
sion of many of the other AARSs in
C. elegans (including those encoding
mitochondrial variants of AARSs) confers
varying degrees of insensitivity to hypo-
xia. Probably the most obvious way in
which cytoplasmic AARS mutations could
confer such resistance is by restricting the
availability of charged tRNA molecules
and thus decreasing the rate of protein
synthesis, thereby conserving valuable
ATP (energy; Figure 1). Anderson et al.
provide two lines of evidence that support
this: first, there is a good correlation
between the extents of protein synthesis
inhibition and protection against hypoxia
observed in worms in which the different
AARSs were knocked down. Second,
a drug that inhibits protein synthesis
(cycloheximide) also induced resistance
to hypoxia-induced death. Interestingly,
Anderson et al. showed that knockdown
of mAARSs also confers hypoxia resis-
tance, albeit to a more limited extent.
Limiting mAARS would be predicted to
reduce ATP synthesis, but also limit
production of reactive oxygen species
(ROS), the toxic byproducts of mitochon-
drial activity. Paradoxically, ROS produc-
tion can increase during hypoxia (Marshall
et al., 1996); thus, knockdown of mAARSs
may play a distinct role in conferring
hypoxia resistance by limiting this toxic
response.
These findings prompt a number of key
questions. First and probably foremost, is
the protein synthesis shutdown demon-
strated by their data only the result of
lack of arginyl tRNA synthetase activity,
or is there additional control over trans-
lation? Most eukaryotes possess a mech-Cell Metaboanism by which accumulation of un-
charged tRNA can regulate translation:
such tRNAs can activate the protein
kinase Gcn2, which phosphorylates a
key translation initiation factor protein,
eIF2, and thereby inhibits binding of ribo-
somes to mRNAs (Wek et al., 2006). This
inhibits general protein synthesis but, in
a seeming paradox, actually enhances
the translation of certain mRNAs. Known
mRNAs regulated this way encode tran-
scription factors that can upregulate,
e.g., expression of amino acid biosyn-
thetic enzymes. While it is not certain
that the C. elegans Gcn2 homolog func-
tions in this way, it is possible that the
mutations in rrt-1 activate a similar
system, and this helps cells to resist, or
recover from, the effects of hypoxia
(although Anderson et al. do not address
this in their study).
The aforementioned Gcn2-based
system is closely related to control of the
unfolded protein response (UPR), acti-
vated when unfolded proteins build up—
for instance during hypoxic stress (Kou-
menis et al., 2007). Accumulation of
unfolded proteins in the endoplasmic
reticulum can activate the protein kinase
PERK, which, like Gcn2, phosphorylates
the translation initiation factor eIF2.
However, Anderson et al. show that the
rrt-1 mutation completely prevented the
induction of the UPR by hypoxia. As ex-
pected, the authors find that loss of func-
tion of the UPR genes ire-1 and xbp-1
impaired the resistance to hypoxia
caused by the rrt-1 mutation, but,
puzzlingly, loss of function of these genes
actually also led to mild resistance to
hypoxia. It is suggested that the ability of
the rrt-1 mutation to promote resistance
to hypoxia in some way suppresses thelism 9, April 8, 2009 ª2009 Elsevier Inc. 309
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Previewscell death that the UPR normally induces
after severe hypoxia.
Since slowing protein synthesis helps
cells (organisms) to survive hypoxia, it
would be surprising if such a hypoxia-
induced inhibition of protein synthesis
had not already evolved as part of the
cellular survival kit. In fact, higher eukary-
otic cells have several ways to inhibit
protein synthesis under conditions where
energy levels fall, such as during hypoxia.
One way this is achieved is to limit tRNA
gene transcription by downregulating
RNA polymerase III activity under hypoxic
conditions (Ernens et al., 2006). Another
response to hypoxia involves the inhibition
of signaling through the mammalian target
of rapamycin complex 1, mTORC1, which
may be inhibited by ATP or oxygen deple-
tion in several ways (Huang and Manning,
2008). Since mTORC1 positively regulates
protein synthesis, such inhibition is ex-
pected to impair protein synthesis, per-
haps with similar beneficial consequences
to impairing RRT-1 function.
Almost all the energy used by protein
synthesis is consumed during elongation,
where the ribosome traverses the mRNA
and makes the new protein. In mammals,






















Figure 1. Protein Synthesis Is a Tightly Controlled, Energy-Consuming Process
Both the ‘‘charging’’ of tRNAs with amino acids and the process of protein synthesis itself consume substan-
tial amounts of metabolic energy, i.e., ATP and GTP. Accumulation of uncharged tRNAs or depletion of ATP/
GTP can inhibit protein synthesis (mRNA translation) through mechanisms involving activation of GCN2 or
eEF2 kinase (eEF2K), or inactivation of mTORC1 (see text for details). After synthesis, new polypeptides
must fold into their correct conformations: failure to do so can trigger the unfolded protein response
(UPR), which slows protein synthesis and also helps increase the cellular capacity for protein folding.310 Cell Metabolism 9, April 8, 2009 ª2009 Elsevier Inc.tion and inactivation of eukaryotic elonga-
tion factor 2 (eEF2), which mediates the
movement of the ribosome along the
mRNA (Horman et al., 2002). This could
represent a natural survival mechanism
akin to the effect of inactivating RRT-1:
in support of this idea, knocking down
eEF2 kinase impairs the ability of heart
muscle cells to withstand hypoxia (Terai
et al., 2005).
The findings of Anderson et al. identify
a strong link between the downregulation
of protein synthesis and resistance to
hypoxic conditions. This discovery fits
with a body of related literature, indicating
that reducing protein synthetic capacity
can increase the ability of a cell to
weather hypoxic conditions. It will be im-
portant to see how widespread these
mechanisms are and whether restricting
the flux through any of the other major
ATP sinks in the cell—such as DNA or
RNA synthesis—also confers resistance
to hypoxia. Whether or not this is the
case will inform the debate about whether
it is the inhibition of protein synthesis
itself, with attendant ATP savings, or
the reduced accumulation of unfolded
proteins, that underlies hypoxia resis-
tance observed in this study.
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